NeuroPace Inc (NPCE) stock
NPCENasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/3077% above fair value
$12.02−0.50 (-3.99%)
Close on Nov 12, 2026Market cap $412.58MP/E –Yield 0.00%
NeuroPace enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
NeuroPace's enterprise value was $436.53M on Nov 11, 2026, against $543.22M a year earlier. Over the last 5 years it ranged from $3.60M to $565.88M, with a median of $265.17M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $436.53M | -14.8% |
| 2025 | Dec 31, 2025 | $512.60M | +52.7% |
| 2024 | Dec 31, 2024 | $335.68M | +26.6% |
| 2023 | Dec 29, 2023 | $265.17M | +7262.8% |
| 2022 | Dec 30, 2022 | $3.60M | -97.9% |
| 2021 | Dec 31, 2021 | $171.31M | – |
See a number that looks wrong?